Cti Biopharma Corp
Pharmaceutical company · Seattle, Washington, United States
Cti Biopharma Corp is a pharmaceutical company headquartered in Seattle, Washington, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $225,000 in total, most recently in 1999. It has reported private securities offerings to the US SEC, most recently $4.1 million sold in a notice filed in 2010.
Cti Biopharma at a glance
What does Cti Biopharma do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $225,000 in total (1999).
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $4.1 million sold (2010).
Frequently asked questions about Cti Biopharma
Where is Cti Biopharma headquartered?
Cti Biopharma Corp is headquartered in Seattle, Washington, United States.
What does Cti Biopharma do?
Cti Biopharma Corp is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Omeros CorpSeattle, Washington, United States
- Chinook Therapeutics, Inc.Seattle, Washington, United States
- Perspective Therapeutics, Inc.Seattle, Washington, United States
- Aptevo Therapeutics Inc.Seattle, Washington, United States
- IPI Legacy Liquidation CoSeattle, Washington, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.